Brain-derived neurotrophic factor in patients with Huntington's disease - Wikidata - wikimedia - TriplyDB

Brain-derived neurotrophic factor in patients with Huntington's disease

Brain-derived neurotrophic factor in patients with Huntington's disease

http://www.wikidata.org/entity/Q33999072

about

Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges Developing stem cell therapies for juvenile and adult-onset Huntington's disease In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure.Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.MicroRNA-124 slows down the progression of Huntington's disease by promoting neurogenesis in the striatum.Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays.Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis.Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patients Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders.Neuroprotective effects of psychotropic drugs in Huntington's disease The fate of cell grafts for the treatment of Huntington's disease: the post-mortem evidence.Challenges of Huntington's disease and quest for therapeutic biomarkers.Primary cilia and autophagic dysfunction in Huntington's disease.Brain-derived neurotrophic factor and airway fibrosis in asthma.Engineered BDNF producing cells as a potential treatment for neurologic disease.miRNAs as biomarkers of neurodegenerative disorders.Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury.Effect of Clotting Duration and Temperature on BDNF Measurement in Human Serum.Modelling the natural history of Huntington's disease progression.Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers.Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum.Association between Obesity and Circulating Brain-Derived Neurotrophic Factor (BDNF) Levels: Systematic Review of Literature and Meta-Analysis

P2860

Q26747603-9121AF17-4D9D-463C-9EB6-0DAC2BCBADA7 Q26775932-F6F73106-9756-4B77-8591-393FEAE0250E Q26799722-03BFC052-3168-49E3-B332-3A731FD1BEAF Q28570135-6779B454-0C68-4458-9DB4-C6018228BF83 Q33720516-7E74C33D-5E26-4CB2-B229-012DAA7F7710 Q34431341-A3069911-E85C-4744-8B97-B8E040D80766 Q35746332-0DBB3223-632A-4983-BB48-C9E5B79E644B Q36279804-CDCE682F-D879-4A91-9D60-02705F95FF6D Q36361793-D56EF3A1-1A34-4F59-994D-ED1BC142757D Q36813115-7333008B-A36B-43E7-850F-815A1D4C4C74 Q37213531-B7C13D7A-C998-4C5A-92D7-B9E2C0145F55 Q37372275-ACC52DB0-B8BF-4F96-AD05-CD0D096CA094 Q37593863-869B7C29-C130-405D-96C2-ACBC9B0D80E1 Q37712452-6915C401-8DCA-49EF-8C4C-A4358696902B Q38106649-91E2574B-D911-44D2-A6D6-CE9048E5882A Q38163877-58125D9F-46F5-4A70-9507-27893C138C2B Q38168592-79BCB5CA-B720-495F-AD6B-27080C4268A1 Q38257697-39D57AA7-13A4-416F-A744-A1D2CEB1EA9A Q38544624-4446C010-7F4D-44F1-A571-4DF7F08FB0D1 Q38776073-7A55FC37-CBA3-4786-B657-16C12943CA98 Q38829577-531F3512-7EDC-433B-BE0E-F46482BC5ECF Q39104808-3421A81F-D91B-4808-A8E3-71D0F2EEAEE0 Q39157121-C9A26793-C536-42A5-8B61-C86B27660984 Q41660458-03FA30BB-CA1C-41DD-BB3B-D8C51A090644 Q41682202-64841B1F-A904-4676-B7B2-82E8B4D0AF5C Q44186888-02A27184-EA7B-4D70-AC5C-B3B7197CCE6A Q44573861-C22B9114-3E71-4C9C-BDE2-BC574A005362 Q45290293-A5EAAA6A-6AAE-40C4-9E56-4642BB58DDA3 Q46110034-404207E3-E4EF-4870-902F-8835993E8B5A Q52721984-6A896E18-1BA6-4628-9540-E3FD1BAFE35A Q55434313-5E295A62-A2A9-4DA8-B9B6-D8A1DD525445 Q58800961-D5B0E30B-64FF-4FD5-8B46-B47C62DFB1D7

P2860

Brain-derived neurotrophic factor in patients with Huntington's disease

http://www.wikidata.org/entity/Q33999072

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Brain-derived neurotrophic factor in patients with Huntington's disease

@ast

Brain-derived neurotrophic factor in patients with Huntington's disease

@en

type

label

Brain-derived neurotrophic factor in patients with Huntington's disease

@ast

Brain-derived neurotrophic factor in patients with Huntington's disease

@en

prefLabel

Brain-derived neurotrophic factor in patients with Huntington's disease

@ast

Brain-derived neurotrophic factor in patients with Huntington's disease

@en

P1433

Q33999072-F7C28D7F-9127-4D93-ADCE-F83CAB54464C

P1476

Q33999072-3A8A2242-3427-4B0C-801B-FA725C70A121

P2093

Q33999072-06F9910C-622B-4E4E-B845-7AFD3D0ED8A3

Q33999072-54987BB5-1095-4CB7-9E2C-2BC6D8B82F64

Q33999072-5D51086D-245F-444C-BC7C-A90423D76A9C

Q33999072-78BF46D1-64E0-4019-B749-B07A37D0F0C6

Q33999072-92D89051-4837-43B2-8529-7AA275ED1836

Q33999072-AB3F60A7-3C03-4DFB-B9E8-5B488F5A689B

Q33999072-B172D2D5-0EF2-42FD-8B4B-EECE9598F69D

P2860

Q33999072-0EAD5BC8-A4BD-4F38-A666-3510AAFE37F6

Q33999072-1BBDB195-3941-4D63-88BA-3FF5095F4CE8

Q33999072-1CC9CF1A-A269-4735-B25C-670432AF3560

Q33999072-1EA8F640-74ED-43C2-94CF-D9B1906BBDE9

Q33999072-223219C5-4A57-4DED-9AD7-7EB0282D1B06

Q33999072-48BC8E11-E3AF-41A7-A075-DD6CB5078660

Q33999072-54BC6ECF-B8E3-4E5F-B15A-B48E1F9CC3A9

Q33999072-5A05B2C7-FA70-49A1-969E-5847FB178617

Q33999072-5C57850B-8B99-4459-8018-8E8BB6234A04

Q33999072-649AE5D6-9445-4A22-9F02-2C4C17EEAA9E

P304

Q33999072-B0792450-DC2B-4394-A4B0-CBE26FF04BA1

P31

Q33999072-B8FD0A1D-FACA-4FE3-B062-36AAF4A53A2A

P356

Q33999072-CF66BB3F-90C8-43C9-84DC-99681A057041

P407

Q33999072-E1CD5E7A-7EAD-493E-9CED-8053722E9E8E

P433

Q33999072-5A4AE414-7EB5-4D83-84C6-88C78538826A

P478

Q33999072-7063E2BB-B12E-4997-8800-06D18379F931

P50

Q33999072-1696EF53-0FC7-4544-8D72-A66A00E94793

Q33999072-27AD8BA1-BE91-4960-806D-67DF7B3EC535

Q33999072-4D228EB4-C443-4FE0-AD12-59E0E88DF753

Q33999072-732334A2-AAD0-45FA-A174-60C3556F8084

Q33999072-8EE3D114-D677-4D11-8BA1-898103415A51

Q33999072-AEA541CE-C5BF-4679-8B40-E4692F5D1F61

Q33999072-F0A907C7-3C52-4094-8A1D-7B386BD94781

P577

Q33999072-118FDB3C-972E-4455-89F1-8ABA3C3688A6

P5875

Q33999072-4FAB5B01-64F0-4AC4-A172-D8FA238024FB

P698

Q33999072-0D6F5840-6151-4AFC-BADD-0CE861643D69

P921

Q33999072-675DBD28-3AAD-4D2F-8A63-3B7D06EA3D1C

P932

Q33999072-069359BA-DC6D-4157-AD74-C166F3890374

P356

JOURNAL.PONE.0022966

P1433

P1476

Brain-derived neurotrophic factor in patients with Huntington's disease

@en

P2093

Alessia Tarditi

http://www.w3.org/2001/XMLSchema#string

Andrea Ciammola

http://www.w3.org/2001/XMLSchema#string

Barbara Vitali

http://www.w3.org/2001/XMLSchema#string

Caterina Mariotti

http://www.w3.org/2001/XMLSchema#string

Jenny Sassone

http://www.w3.org/2001/XMLSchema#string

Manuela Marullo

http://www.w3.org/2001/XMLSchema#string

Stefano Di Donato

http://www.w3.org/2001/XMLSchema#string

P2860

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

Thrombin induces broad spectrum proteolysis in human serum samples.

Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides.

Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data.

Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data.

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

Brain-derived neurotrophic factor in neurodegenerative diseases.

P304

e22966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0022966

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Sarah J. Tabrizi

Anne-Catherine Bachoud-Lévi

P577

2011-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51586782

http://www.w3.org/2001/XMLSchema#string

P698

21857974

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3155522

http://www.w3.org/2001/XMLSchema#string